Background
Despite the gold-standard approach for transaortic valve implantation (TAVI) remains transfemoral (TF), alternative approaches are needed in patients who present contraindications to transfemoral access.
Case summary
We report the case of a 79-year-old female with a symptomatic high gradient severe aortic stenosis - mean gradient of 43 mmHg- and a significant supra-aortic trunk stenosis (left carotid artery: 90-99%; right carotid artery: 50-70 %), and who was hospitalized for progressive dyspnea New York Heart Association (NYHA) stage III.
In this high-risk patient, it was decided to perform a transaortic valve implantation (TAVI). Because of a history of stenting of both common iliac arteries in a context of an arterial insufficiency of the lower limbs (Leriche classification stage III) and stenotic thoraco-abdominal aorta atheromatosis, an alternative approach to the transfemoral transaortic valve implantation (TF-TAVI) one was needed. It was decided to perform a combined Transcarotid-TAVI (TC-TAVI) with EDWARDS S3 23 mm valve with a left endarteriectomy during the same operating time.
Discussion
Our case illustrates an alternative approach to perform a percutaneous aortic valve implantation, despite supra-aortic trunk stenosis, in a high risk surgical patient contraindicated to a TF-TAVI. TC-TAVI remains a safe alternative when transfemoral-TAVI is contraindicated, and the combined approach of CEA and TC-TAVI offers a minimally invasive one-step treatment in high operative risk patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.